Search Results

Showing results 721 - 730 for weill cornell connect patient portal

Monoclonal Antibody for Myosin Fast Muscle Light Chain 2 (MF5) | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/monoclonal-antibody-myosin-fast-muscle-light-chain

Monoclonal Antibody for Neonatal and Adult Myosin Heavy Chain (MF30) | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/monoclonal-antibody-neonatal-and-adult-myosin-heavy

Monoclonal Antibody for Myosin Heavy Chain (MF20) | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/monoclonal-antibody-myosin-heavy-chain-mf20

Monoclonal Antibody for Desmin (D76) | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/monoclonal-antibody-desmin-d76

Monoclonal Antibody for Muscle Fast C-Protein (MF1) | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/monoclonal-antibody-muscle-fast-c-protein-mf1

Monoclonal Antibody for Desmin (D3) | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/monoclonal-antibody-desmin-d3

Monoclonal Antibody for Myosin Heavy Chain (ALD58) | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/monoclonal-antibody-myosin-heavy-chain-ald58

Monoclonal Antibody for Muscle Slow C-Protein (ALD66) | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/monoclonal-antibody-muscle-slow-c-protein-ald66

Anchoring fibrils. A new connective tissue structure in fibrotic lung

...Connect Departments Alumni News Events Weill Cornell Medicine....

https://geneticmedicine.weill.cornell.edu/publications/anchoring-fibrils-new-connective-tissue-structure-fibrotic-lung-disease

New York's Role in Redefining the Life Sciences Landscape with Jennifer Hawks Bland, CEO of NewYorkBIO | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/events/new-yorks-role-redefining-life-sciences-landscape-jennifer-hawks-bland-ceo-newyorkbio

Showing results 721 - 730 for weill cornell connect patient portal